Connective tissue growth factor: A mediator of TGf-β action on fibroblasts

Cytokine and Growth Factor Reviews

Volumn 8, Issue 3, 1997, Pages 171-179

  Grotendorst, Garv R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Development; Fibrotic disorder; Mitogen; Protein structure; Wound repair

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE; EPIDERMAL GROWTH FACTOR; GENE PRODUCT; GROWTH FACTOR; GROWTH PROMOTOR; HEPARIN; MITOGENIC AGENT; PLATELET DERIVED GROWTH FACTOR BB; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL; ANIMAL CELL; ANIMAL TISSUE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; EMBRYO PATTERN FORMATION; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; MOUSE; NONHUMAN; PHYSIOLOGY; PROTO ONCOGENE; RAT; SHORT SURVEY; SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALS; FIBROBLASTS; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGENS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; AVES; MAMMALIA;

EID: 0031225015     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(97)00010-5     Document Type: Short Survey

References (67)

1. Amento EP, Beck LS. TGF-β and wound healing. In Clinical Applications of TGFB1. Wiley, Chichester. Ciba Foundation Symposium 1991, 157, 115-129.
2. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor beta (TGF-β). Growth Factors 1993, 8, 1-9.
3. Wahl SM. Transforming growth factor beta in inflammation. A cause and a cure. J. Immunol. 1992, 12, 61-74.
4. Raghow R. Role of transforming growth factor β in repair and fibrosis. Chest 1991, 99s, 61-65.
5. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Molec. Biol. Cell 1993, 4, 637-645.
6. Levine JH, Moses HL, Gold LI, Nanney LB. Spatial and temproal patterns of immunoreactive transforming growth factor beta 1, beta 2, beta 3 during excisional wound repair. Am. J. Pathol. 1993, 143, 368-380.
7. Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T. Colocalization of TGF-β and type I procollagen mRNA in tissue sections of patients with systemic sclerosis. J. Clin. Invest. 1990, 86, 917-922.
8. Peltonen J, Kahari L, Jaakkola S, Kahari V-M, Varga J, Uitto J, Jimenez SA. Evaluation of TGF-β and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. J. Invest. Dermatol. 1990, 94, 365-371.
9. Smith EA, LeRoy EC. A possible role for transforming growth factor beta in systemic sclerosis. J. Invest. Dermatol. 1990, 95, 125s-127s.
10. Nagy P, Schaff Z, Lapis K. Immunohistochemical detection of TGF-β1 in fibrotic liver disease. Hepatology 1991, 14, 269-273.
11. Kagami S, Border WA, Ruoslahti E, Noble NA. Coordinated expression of beta 1 integrins, and transforming growth factor-beta induced matrix proteins in glomerulonephritis. Lab. Invest. 1993, 69, 68-76.
12. Bahadori L, Milder J, Gold L, Botney M. Active macrophage associated TGF-β colocalizes with type I procollagen gene expression in atheroscierotic human pulmonary arteries. Am. J. Pathol. 1995, 146, 1140-1149.
13. DeLarco JE, Todaro GJ. Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. USA 1978, 75, 4001-4005.
14. Assoian RK, Grotendorst GR, Miller DV, Sporn MB. Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature 1984, 309, 804-806.
15. Leof EB, Proper JA, Gouston AS, Shipley GD, Dicorleto PE, Moses HL. Induction of c-sis mRNA and activity similar to PDGF by TGFβ: a proposed model for indirect mitogenesis involving autocrine activity. Proc. Natl. Acad. Sci. USA 1986, 83, 2453-2457.
16. Soma Y, Grotendorst GR. Transforming growth factor beta stimulates primary human skin fibroblast DNA synthesis via an autocrine production of PDGF-related peptides. J. Cell. Physiol. 1989, 140, 246-253.
17. Ishikawa O, LeRoy EC, Trojanowska M. Mitogenic effect of transforming growth factor beta-1 on human fibroblasts involves the induction of platelet-derived growth factor alpha-receptors. J. Cell. Physiol. 1990, 145, 181-186.
18. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. Transforming growth factor beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine platelet-derived growth factor loop. Cell 1990, 63, 515-524.
19. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 1986, 261, 4337-4345.
20. Roberts AB, Sporn NB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JR, Fauci AS. Transforming growth factor type P: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in-vitro. Proc. Natl. Acad. Sci. USA 1986, 83, 4167-4171.
21. Varga J, Rosenbloom J, Jimenez SA. Transforming growth factor beta causes a persistent increase in steady-state amounts for type I and type III collagen and fibronectin mRNAs in normal dermal human fibroblasts. Bichem. J. 1987, 297, 597-604.
22. Raghow R, Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. Transforming growth factor beta increases steady state levels of type I procollagen and fibronectin mRNAs posttranslationally in cultured fibroblasts. J. Clin. Invest. 1987, 79, 1285-1288.
23. Penttinen RP, Kobayashi S, Bornstein P. Transforming growth factor P increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc. Natl. Acad. Sci. USA 1988, 85, 1105-1108.
24. Laiho M, Saksela O, Andreasen PA, Keski-Oja J. Enhanced productin and extracellular deposition of the endothelial-type plaminogen activator inhibitor in cultured human lung fibroblasts by Transforming growth factor β. J. Cell. Biol. 1986, 103, 2403-2410.
25. Lund LR, Riccio A, Andreasen PA, Nielsen LS, Kristensen P, Laiho M, Saksela O, Blasi F, Dano K. Transforming growth factor-β is a strong and fast acting positive regulator of the level of type-I plaminogen activator-inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J. 1987, 6, 1281-1286.
26. Kerr LD, Miller DB, Matrisian LM. TGFβl inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 1990, 61, 267-278.
27. Kothapalli D, Frazier K, Grotendorst GR. TGF-β induces anchorage-independent growth of NRK fibroblasts via the synergistic action of CTGF-dependent and CTGF-independent signalling pathways. Cell Growth and Differentiation 1997, 8, 61-68.
28. Bradham DM, Igarshi A, Potter RL, Grotendorst GR. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J. Cell Biol. 1991, 114, 1285-1294.
29. Simmons DL, Levy DB, Yannoni Y, Erikson RL. Identification of a phorbol ester-repressible v-src-inducible gene. Proc. Nad. Acad. Sci. USA 1989, 86, 1178-1182.
30. O'Brien TP, Yang GP, Sanders L, Lay LF. Expression of cyr61, a growth factor-inducible immediate early gene. Molec. Cell. Biol. 1990, 10, 3569-3577.
31. Ryseck R-P, Macdonald-Bravo H, Mattei M-G, Bravo R. Structure, mapping and expression of Fisp-12, a growth factor inducible gene encoding a cysteine-rich protein. Cell Growth Differ. 1991, 2, 225-233.
32. Joliot V, Marinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J, Perbal B. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis associated virus type-I induced nephroblastomas. Molec. Cell. Biol. 1992, 12, 10-21.
33. Brunner A, Chinn J, Neubauer M, Purchio AF. Identification of a gene family regulated by transforming growth factor beta. DNA Cell Biol. 1991, 10, 293-300.
34. Perbal B, Scholfeild P, Boulter C. Genomic structure and chromosomal mapping of the mouse nov gene. Genomics 1996, 38, 425-428.
35. Ying Z, King ML. Isolation and characterization of xnov, a Xenopus laevis analog of the chicken nov gene. Gene 1996, 171, 243-248.
36. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Letters 1993, 327, 125-130.
37. Mason ED, Konrad KD, Webb CD, Marsh JL. Dorsal midline fate in Drosophila embryos requires twisted gastrulation, a gene encoding a secreted protein related to human connective tissue growth factor. Genes Develop. 1994, 8, 1489-1501.
38. Kiefer MC, Masiarz FR, Bauer DM, Zapf J. Identification and molecular cloning of two new 30-kDa insulin-like growth factor binding proteins isolated from adult human serum. J. Biol. Chem. 1991, 266, 9043-9049.
39. Francois V, Bier E. Xenopus chordin and Drosophila short gastrulation genes encode homologous proteins functioning in dorsal-ventral axis formation. Cell 1995, 80, 19-20.
40. Piccolo S, Sasai Y, Lu B, De Robertis EM. Dorsoventral patterning in Xenopus: Inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 1996, 86, 589-598.
41. Probst JC, Hauser F, Joba W, Hoffmann W. The polymorphic integumentary mucin B. l from Xenopus laevis contains the short consensus repeat. J. Biol. Chem. 1992, 267, 6310-6316.
42. 4)βl-l Cer] and has a sequence homology with other proteins that bind sulfated glycoconjugates. J. Biol. Chem. 1990, 265, 2852-2855.
43. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR. Stimulation of fibroblast cell growth, matrix production and granulation tissue formation by connective tissue growth factor. J. Invest. Dermatol. 1996, 107, 404-411.
44. Kireeva ML, Mo F-E, Yang GP, Lau LF. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration and adhesion. Molec. Cell. Biol. 1996, 16, 1326-1334.
45. Thomas KA, Rios-Candelore M, Fitzpatrick S. Purification and characterization of acidic fibroblast growth factor from bovine brain. Proc. Natl. Acad. Sci. USA 1984, 81, 357-361.
46. Marikovsky M, Breuing K, Liu P, Eriksson E, Higashiyami S, Farber P, Abraham J, Klagsburn M. Appearance of a heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc. Natl. Acad. Sci. USA 1993, 90, 3889-3893.
47. Thornton SC, Mueller SN, Levine EM. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 1983, 222, 623-625.
48. Murray-Rust J, McDonald NQ, Blundell TL, Hosang M, Oefner C, Winkler F, Bradshaw RA. Topological similarities in TGF-beta 2, PDGF BB and NGF define a superfamily of polypeptide growth factors. Structure 1993, 1, 153-159.
49. Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Diff. 1996, 7, 469-480.
50. Mathews LS, Vale WW. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 1991, 65, 973-982.
51. Ohtsuki M, Massague J. Evidence for the involvement of protein kinase activity in transforming growth factor-β signal transduction. Molec. Cell. Biol. 1992, 12, 261-265.
52. Ulrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990, 61, 203-212.
53. Williams LT, Escobedo JA, Fantl WJ, Turck CW, Klippel A. Interactions of growth factor receptors with cytoplasmic signalling molecules. Cold Spring Harbor Symp. Quart. Biol. 1991, 56, 243-250.
54. Cochran BH, Reffel AC, Stiles CD. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 1983, 33, 939-947.
55. Greenberg ME, Ziff EB. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 1984, 311, 433-438.
56. de Groot RP, Kruijer W. Transcriptional activation by TGF-βl mediated by the DYAD symmetry element (DSE) and the TPA responsive element (TRE). Biochem. Biophys. Res. Commun. 1990, 168, 1074-1981.
57. Kim S-J, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M, Roberts AB. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Molec. Cell. Biol. 1990, 10, 1492-1497.
58. Oikarinen J, Hatamochi A, de Crombrugghe B. Separate binding sites for nuclear factor 1 and a CCAAT DNA binding factor in the mouse α2(l) collagen promoter. J. Biol. Chem. 1987, 262, 11064-11070.
59. Riccio A, Pedone PV, Lund LR, Olesen T, Olsen HS, Andreasen PA. Transforming growth factor β1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor 1 in the type 1 plasminogen activator inhibitor gene. Molec. Cell. Biol. 1992, 12, 1846-1855.
60. Edwards DR, Heath JK. Regulation of transcription by transforming growth factor-β. In The Hormonal Control Regulation of Gene Transcription ed. P. Cohen and J. G. Foulkes. Elsevier, Amsterdam, 1991, 333-347.
61. Kerr LD, Miller DB, Matrisian LM. TGF-βl inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 1990, 61, 267-278.
62. Pietenpol JA, Holt JT, Stein RW, Moses HL. Transforming growth factor β1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci. USA 1990, 87, 3758-3762.
63. Gospodarowicz D, Plouet J, Malerstein B. Comparison of the ability of basic and acidic fibroblast growth factor to stimulate the proliferation of an established keratinocyte cell line: modulation of their biological effects by heparin, transforming growth factor Beta and epidermal growth factor. J. Cell. Physiol. 1990, 142, 325-333.
64. Robinson CJ, Ayling CM, Gray E, Mulloy B. Potentiation of the action of fibroblast growth factor by heparin and related molecules. Biochem. Soc. Trans. 1993, 21, 485-486.
65. Besner GE, Whelton D, Crissman-Combs MA, Steffen CL, Kim GY, Brigstock DR. Interaction of heparin-binding EGF-like growth factor with the EGF receptor: modulation by heparin, heparinase, or synthetic heparin-binding EGF fragments. Growth Factors 1992, 7, 289-296.
66. Damon DH, Lobb RR, D' Amore PA, Wagner JA. Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life. J. Cell. Physiol. 1994, 138, 221-226.
67. Roghani M, Mansulchani A, Dell'era P, Bellosta P, Basilico C, Rifkin DB, Moscatelli D. Heparin increases the affinity of bFGF for its receptor but is not required for binding. J. Biol. Chem. 1994, 269, 3976-3984.